These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2956303)

  • 1. Age and gender effects on the diagnostic power of the DST.
    Ansseau M; Depauw Y; Charles G; Castro P; D'Haenen H; De Vigne JP; Hubain P; Legros JJ; Pelc I; Toscano A
    J Affect Disord; 1987; 12(3):185-91. PubMed ID: 2956303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
    Lemus CZ; Asnis GM; Halbreich U; Harkavy Friedman JM; Van Praag HM; Rubinson E; Eisenberg J
    J Affect Disord; 1987; 12(3):219-21. PubMed ID: 2956306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 5. Age effects in serial hypothalamic-pituitary-adrenal monitoring.
    Greden JF; Flegel P; Haskett R; Dilsaver S; Carroll BJ; Grunhaus L; Genero N
    Psychoneuroendocrinology; 1986; 11(2):195-204. PubMed ID: 3749402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression.
    Extein I; Pottash AL; Gold MS
    Psychoneuroendocrinology; 1985; 10(3):281-8. PubMed ID: 4059475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of weight loss on the dexamethasone suppression test.
    Yerevanian BI; Baciewicz GJ; Iker HP; Privitera MR
    Psychiatry Res; 1984 Jun; 12(2):155-60. PubMed ID: 6591220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patients.
    Halbreich U; Olympia J; Carson S; Glogowski J; Yeh CM; Axelrod S; Desu MM
    Psychoneuroendocrinology; 1989; 14(5):365-70. PubMed ID: 2813658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dex/CRH test--is it better than the DST?
    Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
    Arana GW; Wilens TE; Baldessarini RJ
    Psychoneuroendocrinology; 1985; 10(1):49-60. PubMed ID: 4001277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients.
    Axelson DA; Doraiswamy PM; Boyko OB; Rodrigo Escalona P; McDonald WM; Ritchie JC; Patterson LJ; Ellinwood EH; Nemeroff CB; Krishnan KR
    Psychiatry Res; 1992 Oct; 44(1):63-70. PubMed ID: 1461948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated dexamethasone suppression test in depressed patients.
    Maes M; De Ruyter M; Hobin P; Suy E
    J Affect Disord; 1986; 11(2):165-72. PubMed ID: 2948992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of abnormal dexamethasone suppression test in alcoholics abstinent for four weeks.
    Del Porto JA; Monteiro MG; Laranjeira RR; Jorge MR; Masur J
    Biol Psychiatry; 1985 Nov; 20(11):1156-60. PubMed ID: 4052517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and the dexamethasone suppression test: results from a broad unselected patient population.
    Keitner GI; Ryan CE; Kohn R; Miller IW; Norman WH; Brown WA
    Psychiatry Res; 1992 Oct; 44(1):9-20. PubMed ID: 1461951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.